Effect of the MTHFRC677T variant on risk of venous thromboembolism: Interaction with factor V leiden and prothrombin (F2G20210A) mutations

British Journal of Haematology

Volumn 103, Issue 1, 1998, Pages 42-44

  Brown, Karen ^a   Luddington, Roger ^a   Baglin, Trevor ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Factor V Leiden; Methylenetetrahydrofolate reductase; Prothrombin; Thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; CHILD; FACTOR V; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM;

EID: 0031713550     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00935.x     Document Type: Article

References (12)

1. Arruda, V., von-Zuben, P., Chiaparini, L., Annichino-Bizzacchi, J. & Costa, F. (1997) The mutation Ala677Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thrombosis and Haemostasis, 77, 818-821.
2. Brown, K., Williamson, D., Luddington, R., Baker, P. & Baglin, T. (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. British Journal of Haematology, 98, 907-909.
3. Brugada, R. & Marian, A. (1947) A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Athersclerosis, 128, 107-112.
4. Cattaneo, M., Tsai, M., Bucciarelli, P., Taioli, E., Bignell, M. & Mannucci, P. (1947) A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V: Q506). Arteriosclerosis Thrombosis and Vascular Biology, 17, 1662-1666.
5. den-Heijer, M., Koster, T., Blom, H., Bos, G., Briet, K., Reitsma, P., Vandenbroucke, J. & Rosendaal, F. (1996) Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 334, 759-762.
6. Frosst, P., Blom, H., Milos, R., Goyette, P., Sheppard, C., Mathews, R., Boers, G., den Heijer, M., Kluijtmans, L., van den Heuvel, L. & Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111-113.
7. Ma, J., Stampfer, M., Hennekens, C., Frosst, P., Selhub, J., Horsford, J., Malinow, M., Willett, W. & Rozen, R. (1996) Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation, 94, 2410-2416.
8. Nygard, O., Nordrehaug, J., Refsum, H., Ueland, P., Farstad, M. & Vollset, S. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine, 337, 230-236.
9. Salden, A., Keeney, S., Hay, C. & Cumming, A. (1997) The C677T MTHFR variant and the risk of venous thrombosis. (Letter). British Journal of Haematology, 99, 472.
10. Simioni, P., Prandoni, P., Burlina, A., Tormene, D., Sardella, C., Ferrari, V., Benedetti, L. & Girolami, A. (1996) Hyperhomocysteinaemia and deep-vein thrombosis. Thrombosis and Haemostasis, 76, 883-886.
11. Tosetto, A., Missiaglia, E., Frezzato, M. & Rodeghiero, F. (1997) The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism. British Journal of Haematology, 97, 804-806.
12. van-Bockxmeer, F., Mamotte, C., Vasikaran, S. & Taylor, R. (1997) Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation, 95, 21-23.